Kelly Maurer
Overview
Explore the profile of Kelly Maurer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
541
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beigel K, Wang X, Song L, Maurer K, Breen C, Taylor D, et al.
Clin Epigenetics
. 2024 Nov;
16(1):159.
PMID: 39543716
Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations. There is little understanding of why some organs are specifically impacted in patients and the mechanisms of disease...
2.
Ma X, Dawany N, Kondo A, Maurer K, Karakasheva T, Shraim R, et al.
bioRxiv
. 2024 Oct;
PMID: 39386555
Cytokines mediating epithelial and immune cell interactions modulate mucosal healing- a process that goes awry with chronic inflammation as in inflammatory bowel disease. TNFSF13 is a cytokine important for B...
3.
Frusone V, Maurer K, Emanuel B, McDonald-McGinn D, Sullivan K
J Clin Immunol
. 2024 Mar;
44(3):82.
PMID: 38488991
No abstract available.
4.
Patel S, Russo P, M H, Maurer K, Hao L, Beard R, et al.
Pediatr Allergy Immunol
. 2024 Jan;
35(1):e14082.
PMID: 38284923
No abstract available.
5.
Costa-Reis P, Maurer K, Petri M, Erez D, Zhao X, Faig W, et al.
Lupus Sci Med
. 2022 Aug;
9(1).
PMID: 35918102
Objective: Lupus nephritis is a key driver of morbidity and mortality in SLE. Detecting active nephritis on a background of pre-existing renal damage is difficult, leading to potential undertreatment and...
6.
Kelsen J, Dawany N, Conrad M, Patel T, Devoto M, Maurer K, et al.
Clin Immunol
. 2022 May;
240:109047.
PMID: 35613698
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract. Treatment for patients who have a monogenic cause of their IBD, often the youngest children, known...
7.
Zhang Z, Shi L, Song L, Maurer K, Zhao X, Zackai E, et al.
J Clin Immunol
. 2021 Aug;
41(8):1853-1864.
PMID: 34435264
Purpose: Chromosome 22q11.2 deletion syndrome is a common inborn error of immunity. The early consequences of thymic hypoplasia are low T cell numbers. Later in life, atopy, autoimmunity, inflammation, and...
8.
Ruffner M, Zhang Z, Maurer K, Muir A, Cianferoni A, Sullivan K, et al.
Clin Transl Immunology
. 2021 Jul;
10(7):e1314.
PMID: 34322233
Objective: There are no disease-modifying therapies for the treatment of eosinophilic oesophagitis (EoE), which is driven by non-IgE-mediated allergic inflammation. A recent clinical trial of milk epicutaneous immunotherapy (EPIT) has...
9.
Dou Y, Maurer K, Conrad M, Patel T, Shraim R, Sullivan K, et al.
J Pediatr Gastroenterol Nutr
. 2021 Jun;
73(4):529-536.
PMID: 34117197
Objectives: Very early-onset inflammatory bowel disease (VEO-IBD) arises in children less than 6 years old, a critical time for immunologic development and maturation of the intestinal microbiome. Non-conventional lymphocytes, defined...
10.
Le Coz C, Nguyen D, Su C, Nolan B, Albrecht A, Xhani S, et al.
J Exp Med
. 2021 May;
218(7).
PMID: 33951726
The pioneer transcription factor (TF) PU.1 controls hematopoietic cell fate by decompacting stem cell heterochromatin and allowing nonpioneer TFs to enter otherwise inaccessible genomic sites. PU.1 deficiency fatally arrests lymphopoiesis...